Hansa Biopharma AB (24H.F) Q1 2026 Earnings

11FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.23
-0.17
-0.11
-0.05

Details

Expected EPS
-0.143592900673216
Actual EPS
-0.14760315072
Surprise EPS
-0
Surprise Percent
+2.79%

Description

Hansa Biopharma AB (24H.F) has reported earnings of -0.14760315072 per share for Q1 2026.

0 Comments

Share your thoughts